The highly contagious SARS-CoV-2 virus, which causes coronavirus disease 2019 (COVID-19), emerged at the close of 2019 and has led to a medical crisis across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020.
The pandemic has now killed over 2.1 million people worldwide. This sobering milestone comes just one year after the first death was reported on January 11, 2020 in China. The virus has spread to 195 countries, with more than 99 million confirmed cases.
The virus has significantly impacted the global economy and employment rates. All industries have been affected in some way, with some such as travel, tourism, and hospitality decimated.
This report provides an overview of the impact of COVID-19 across the pharmaceutical industry in 2020.
This report assesses the impact of COVID-19 across the pharmaceutical industry in 2020 and includes information from existing publications as well as additional data and analysis from the Pharmaceutical Intelligence Center.
The report includes the following areas –
– Drug development
– Clinical trials and regulation
– Supply chain
– Business development and licensing
– Financial performance
– Sales and marketing
– Emerging technologies
Reasons to buy
Get a comprehensive overview of the impact of COVID-19 on different sectors of the pharmaceutical industry with analysis from GlobalData’s core datasets, surveys, and polls.
See how emerging technologies have played a key role during the pandemic.
See how the pandemic will continue to shape the industry in 2021.
Table of Contents
Clinical Trials and Regulatory
Business Development & Licensing
Sales & Marketing
About the Authors